Patient Monitoring Devices Global Market - Forecast to 2027

Patient Monitoring Devices Global Market - Forecast to 2027

Patient monitoring devices assist in continuous measurement of a patient’s health parameters such as heart rate, respiratory rate, blood pressure, blood oxygen saturation and many other parameters which have become a common feature of all healthcare settings. The Patient monitoring global market is expected to grow at a mid single digit CAGR fom 2020 to 2027 to reach $42,974.9 million by 2027. The increase in the rate of surgeries and diseased population requires continuous monitoring, increasing demand for portable and remote patient monitoring and increasing funding and investment in patient monitoring are driving the market growth. However, the high cost of patient monitoring devices, stringent regulatory approvals for products, Patient safety and inaccuracy concerns associated with patient monitoring devices, increased product recalls are restraining the market growth.
The patient monitoring devices global market is segmented based on device, portability, end-users and geography. The devices market is segmented into neuromonitoring, hemodynamic monitoring, blood glucose monitoring, cardiac monitoring, fetal & neonatal care monitoring, respiratory care monitoring, multi-parameter monitoring, temperature monitoring and remote patient monitoring. According to IQ4I research, Blood glucose monitoring commanded the largest revenue in 2020 and expected to grow at a low single digit CAGR from 2020 to 2027. Remote patient monitoring is expected to grow at a high single digit CAGR from 2020 to 2027 due to increasing demand by patients for home healthcare and increasing connectivity of rural areas.
The neuromonitoring devices global market is further segmented into electroencephalography (EEG) devices, cerebral oximeters, intracranial pressure (ICP) monitors, magnetoencephalography (MEG) and electromyography machines (EMG). Among them, the EEG devices segment commanded the largest revenue in 2020 is expected to grow at a high single digit CAGR from 2020 to 2027. Increasing the incidence of neurological diseases, expansion of application to new areas such as pain monitoring are the factors driving the market growth.
The hemodynamic monitoring devices global market is classified into Blood pressure monitors and cardiac output monitors. Among them, the Blood pressure monitoring devices commanded the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027. An increase in the incidence of cardiovascular diseases due to lifestyle changes and rising demand for patient monitoring devices in non-hospital settings are the factors driving the market.
The blood glucose monitoring devices global market is classified into SBGM and CGM. Among the segments, CGM generated the largest revenue in 2020 and is expected to grow at a high single digit CAGR from 2020 to 2027.
The cardiac monitoring device global market is further segmented into event monitors, 12-Lead ECG and Holter monitors, among these, Holter monitor commanded the largest revenue in 2020 and expected to grow at a mid single digit CAGR from 2020 to 2027. Event Monitors market is expected to grow at a high single digit CAGR from 2020 to 2027.
The fetal and Neonatal device global market is classified into fetal monitors, fetal Doppler, infant incubators and neonatal monitoring devices. Among these, fetal monitors commanded the largest revenue in 2020 and expected to grow at a low single digit CAGR from 2020 to 2027. Infant Incubators market is expected to grow at a mid single digit CAGR from 2020 to 2027.
The respiratory care monitoring devices global market is classified into capnography, spirometer, Polysomnography (PSG), Pulse oximetry and others. Among these, Pulse oximeter commanded the largest revenue in 2020 and is expected to grow at a low single digit CAGR from 2020 to 2027. Rising incidence of respiratory and cardiac disorders, rising adoption in homecare settings, growing demand for wireless pulse oximeters and launch of convenient fingertip and wrist pulse oximeters are the factors driving the market. The Capnography devices segment is expected to grow a high single digit CAGR from 2020 to 2027.
The Multi-parameter monitoring devices global market is segmented into High acuity, Mid-acuity, and Low-acuity devices. Among the multi-parameter monitoring devices, high acuity devices commanded the largest revenue in 2020 and expected to grow at a low single digit CAGR from 2020 to 2027. The integration of advanced technology within the high-acuity multi-parameter patient monitors has fostered its adoption in intensive care units and hospitals that help in the treatment of several chronic diseases are the factors driving the market and low acuity segment is expected to grow at a low single digit CAGR from 2020 to 2027. Low-acuity monitors usually have a high preference in ambulatory surgical centers and hospitals because they are easy to use, accurate, mobile and low price as compared to the high-acuity multi-parameter patient monitors are making the device of choice.
The temperature monitoring devices global market is classified into digital thermometers, Infrared (IR) thermometers, and others (thermometer strips). Among them, the IR thermometer commanded the largest revenue in 2020 and is expected to grow at a strong mid single digit CAGR from 2020 to 2027. These devices do not involve touching or contacting anybody's surface so the risk of cross-infection is negligible, the increasing prevalence of chronic and infectious diseases driving the market as well.
The remote patient monitoring (RPM) devices are classified into hemodynamic monitoring devices, neuromonitoring devices, cardiac monitoring devices and multi-parameter monitoring devices and others. Among these, the Cardiac monitoring segment commanded the largest revenue in 2020 and is expected to grow at a high single digit CAGR from 2020 to 2027. An increase in the prevalence of the cardiac disorder, an increase in the prevalence of the geriatric population who are more prone to chronic disorders are the factors that increase the usage of RPM devices. Other remote patient monitoring devices such as remote respiratory monitoring devices and home dialysis devices are expected to be the fastest-growing segment with a high double digit CAGR from 2020 to 2027.
The patient monitoring devices global market is further segmented based on the portability into stationary, portable, wearable and implantable. Among these, portable commanded the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027.
The patient monitoring devices global market based on end-user is segmented into hospital, ambulatory, homecare and others. Among these, the hospital commanded the largest revenue in 2020 and is expected to grow at a low single digit CAGR from 2020 to 2027. The home care market is expected to be the fastest-growing segment with a mid single digit CAGR from 2020 to 2027 due to the improvement and acceptance of home care devices has increased.
The market based on geographies is segmented into North America, Europe, Asia Pacific and the Rest of the world regions. Among these, North America commanded the largest share in 2020 and the market is expected to grow at a low single digit CAGR from 2020 to 2027. An increase in patient population and an increase in funding on developing patient monitoring devices are the factors driving the market. Asia Pacific is expected to grow at a mid single digit CAGR from 2020 to 2027.
Major players in the patient monitoring devices global market are Medtronic, PLC (Ireland), Dexcom, Inc. (U.S.), Masimo Corporation (Switzerland), Abbott Laboratories (U.S.), Nihon Kohden Corporation (Japan), Edwards Lifesciences Corporation (U.S.), GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Hill-Rom Holdings, Inc. (U.S.), Natus Medical, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), and Dragerwerk AG & Co. KGaA (Germany).


1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increase in the rate of surgeries and diseased population require
continuous monitoring.
3.3.1.2 Increasing demand for portable and remote patient monitoring devices.
3.3.1.3 Increasing funding and investment in patient monitoring technologies.
3.3.1.4 Increase in demand for patient monitoring devices in emerging nations
3.3.1.5 Favorable reimbursement policies
3.3.1.6 Technological advancements
3.3.1.7 Availability of services such as home healthcare and nursing care increasing
the demand for the use of patient monitoring devices
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 High cost of patient monitoring devices
3.3.2.2 Patient safety issues and inaccuracy concern associated with patient
monitoring devices
3.3.2.3 Increased product recalls
3.3.2.4 Lack of cyber-security in wireless patient monitoring devices
3.3.2.5 Stringent regulatory requirements for new products
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO 9001: 2015 Quality Management System
3.4.1.2 ISO 13485 Medical Devices
3.4.2 U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 CHINA
3.4.6 INDIA
3.4.7 JAPAN
3.5 TECHNOLOGICAL ADVANCEMENTS
3.5.1 BIOSTICKER
3.5.2 ARTIFICIAL INTELLIGENCE IN PATIENT MONITORING DEVICES
3.5.3 WEARABLE PATIENT MONITORING DEVICES
3.5.4 IOT IN PATIENT MONITORING SYSTEM
3.5.5 HOME DIALYSIS REMOTE PATIENT MONITORING SYSTEM
3.5.6 SMART ALGORITHMS INTEGRATED HOLTER MONITORING SYSTEMS
3.5.7 FUNCTIONAL NEAR-INFRARED SPECTROSCOPY (FNIRS)
3.5.8 A TRICORDER PHOTOTYPE FOR DIAGNOSIS AND MONITORING OF MULTI PARAMETER AT HOME
3.5.9 WEARABLE TECHNOLOGY FOR CONTINUOUS, NON-INVASIVE BLOOD PRESSURE MONITORING
3.5.10 SMART SPEAKERS FOR MONITORING CARDIAC ARREST
3.5.11 WIRELESS NEONATAL BODY MONITORS
3.5.12 LIQUID METAL BIOSENSORS FOR MONITORING
3.6 PORTER’S FIVE FORCE ANALYSIS
3.6.1 THREAT OF NEW ENTRANTS
3.6.2 THREAT OF SUBSTITUTES
3.6.3 RIVALRY AMONG EXISTING COMPETITORS
3.6.4 BARGAINING POWER OF SUPPLIERS
3.6.5 BARGAINING POWER OF BUYERS
3.7 SUPPLY CHAIN ANALYSIS
3.8 CLINICAL TRIALS
3.9 MARKET SHARE ANALYSIS
3.9.1 PATIENT MONITORING DEVICES GLOBAL MARKET SHARE ANALYSIS
3.9.2 EEG GLOBAL MARKET SHARE ANALYSIS
3.9.3 CEREBRAL OXIMETER GLOBAL MARKET SHARE ANALYSIS
3.9.4 ICP GLOBAL MARKET SHARE ANALYSIS
3.9.5 BP MONITOR GLOBAL MARKET SHARE ANALYSIS
3.9.6 CARDIAC OUTPUT MONITORS GLOBAL MARKET SHARE ANALYSIS
3.9.7 CONTINUOUS GLUCOSE MONITORING GLOBAL MARKET SHARE
ANALYSIS
3.9.8 CARDIAC MONITORING DEVICES GLOBAL MARKET SHARE ANALYSIS
3.9.9 PULSE OXIMETER GLOBAL MARKET SHARE ANALYSIS
3.9.10 CAPNOGRAPHY GLOBAL SHARE ANALYSIS
3.9.11 MULTIPARAMETER MONITORS DEVICES GLOBAL MARKET SHARE ANALYSIS
3.9.12 REMOTE PATIENT MONIORING DEVICES GLOBAL MARKET SHARE ANALYSIS
3.9.13 TEMPERATURE MONITOR GLOBAL MARKET SHARE ANALYSIS
3.9.14 MOBILE CARDIAC TELEMETRY GLOBAL MARKET SHARE ANALYSIS
3.10 PATIENT MONITORING DEVICES NUMBER OF UNITS SOLD AND
INSTALLED BASE
3.10.1 NEUROMONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
3.10.2 CARDIAC MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
3.10.3 FETAL AND NEONATAL MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
3.10.4 RESPIRATORY MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
3.10.5 TEMPERATURE MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
3.10.6 HEMODYNAMIC MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
3.10.7 MULTI-PARAMETER MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
3.10.8 BLOOD GLUCOSE MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
4 PATIENT MONITORING DEVICES MARKET, BY DEVICES
4.1 INTRODUCTION
4.2 NEUROMONITORING DEVICES
4.2.1 ELECTROENCEPHALOGRAPH (EEG)
4.2.1.1 8-CHANNEL EEG
4.2.1.2 21-CHANNEL EEG
4.2.1.3 25-CHANNEL EEG
4.2.1.4 32-CHANNEL EEG
4.2.1.5 40-CHANNEL EEG
4.2.1.6 MULTI-CHANNEL EEG
4.2.2 CEREBRAL OXIMETER
4.2.2.1 CEREBRAL OXIMETER MONITOR
4.2.2.2 CEREBRAL OXIMETER SENSORS
4.2.2.3 SINGLE EMITTER DUAL DETECTOR
4.2.2.4 DUAL EMITTER DUAL DETECTOR
4.2.2.5 FOUR EMITTERS DUAL DETECTOR
4.2.2.6 FIVE EMITTERS DUAL DETECTOR
4.2.2.7 OTHER SENSORS
4.2.3 INTRACRANIAL PRESSURE MONITORS (ICP)
4.2.4 MAGNETOENCEPHALOGRAPH (MEG)
4.2.5 ELECTROMYOGRAPH MACHINES (EMG)
4.3 HEMODYNAMIC MONITORING
4.3.1 BLOOD PRESSURE MONITORS
4.3.2 CARDIAC OUTPUT MONITORING
4.4 BLOOD GLUCOSE MONITORS
4.4.1 SELF BLOOD GLUCOSE MONITORING (SBGM)
4.4.1.1 BLOOD GLUCOSE METER
4.4.1.2 BLOOD GLUCOSE TESTING STRIPS
4.4.1.3 LANCETS
4.4.1.4 OTHERS
4.4.2 CONTINUOUS GLUCOSE MONITORING (CGM)
4.4.2.1 GLUCOSE SENSORS
4.4.2.2 TRANSMITTER AND RECEIVERS
4.5 CARDIAC MONITORING DEVICES
4.5.1 12-LEADS ECG MONITORS
4.5.2 EVENT MONITORS
4.5.3 HOLTER MONITORS
4.6 FETAL AND NEONATAL MONITORING DEVICES
4.6.1 FETAL MONITORS
4.6.2 FETAL DOPPLER
4.6.3 INFANT INCUBATORS
4.6.4 NEONATAL MONITORING DEVICES
4.7 RESPIRATORY MONITORING DEVICES
4.7.1 CAPNOGRAPHY
4.7.2 SPIROMETER
4.7.2.1 Volumetric Spirometers
4.7.2.2 Flow Measuring Spirometers
4.7.3 POLYSOMNOGRAPHY DEVICES
4.7.4 PULSE OXIMETERS
4.7.4.1 Fingertip pulse oximeters
4.7.4.2 Handheld pulse oximeters
4.7.4.3 Tabletop Pulse Oximeters
4.7.4.4 Other Pulse Oximeters
4.7.5 OTHER RESPIRATORY DEVICES
4.8 MULTI-PARAMETER MONITORING DEVICES
4.8.1 HIGH-ACUITY
4.8.2 MID-ACUITY
4.8.3 LOW-ACUITY
4.9 TEMPERATURE MONITORING DEVICES
4.9.1 DIGITAL THERMOMETERS
4.9.2 INFRARED THERMOMETERS (IR THERMOMETERS)
4.9.3 OTHERS (THERMOMETER STRIPS)
4.10 REMOTE PATIENT MONITORING DEVICES (RPM)
4.10.1 REMOTE NEUROMONITORING DEVICES
4.10.2 REMOTE HEMODYNAMIC MONITORING DEVICES
4.10.3 REMOTE CARDIAC MONITORING DEVICES
4.10.4 IMPLANTABLE LOOP RECORDER/ECG MONITOR
4.10.5 MOBILE CARDIAC TELEMETRY (MCT/MCOT)
4.10.6 REMOTE MULTI-PARAMETER MONITORING DEVICES
4.10.7 OTHER REMOTE MONITORING DEVICES
5 PATIENT MONITORING DEVICES GLOBAL MARKET, BY PORTABILITY
5.1 INTRODUCTION
5.2 STATIONARY PATIENT MONITORING
5.3 PORTABLE PATIENT MONITORING
5.4 WEARABLE PATIENT MONITORING
5.5 IMPLANTABLE PATIENT MONITORING
6 PATIENT MONITORING GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 AMBULATORY SURGICAL CENTERS
6.4 HOME HEALTHCARE
6.5 OTHERS (SLEEP CENTERS, CLINICS/PHYSICIAN OFFICES, HOSPICES)
7 PATIENT MONITORING DEVICES GLOBAL MARKET BY REGION
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 REST OF NORTH AMERICA
7.3 EUROPE
7.3.1 GERMANY
7.3.2 FRANCE
7.3.3 U.K.
7.3.4 REST OF E.U.
7.4 APAC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 REST OF APAC
7.5 ROW
7.5.1 BRAZIL
7.5.2 REST OF LATAM
7.5.3 MIDDLE EAST AND OTHERS
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 APPROVALS
8.3 AGREEMENTS, PARTNERSHIP AND COLLABORATION
8.4 NEW PRODUCT LAUNCH
8.5 ACQUISITION
8.6 OTHERS
9 MAJOR PLAYER PROFILES
9.1 ABBOTT LABORATORIES
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 DEXCOM, INC.
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 DRAGERWERK AG & CO. KGAA
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 EDWARDS LIFESCIENCES CORPORATION.
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 HILL-ROM HOLDINGS, INC.
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 KONINKLIJKE PHILIPS N.V.
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 MASIMO CORPORATION
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 MEDTRONIC, PLC
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 NIHON KOHDEN CORPORATION.
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
9.11 OMRON CORPORATION
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCT PORTFOLIO
9.11.4 KEY DEVELOPMENTS
9.11.5 BUSINESS STRATEGY
9.11.6 SWOT ANALYSIS
9.12 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONIC CO., LTD.
9.12.1 OVERVIEW
9.12.2 FINANCIALS
9.12.3 PRODUCT PORTFOLIO
9.12.4 KEY DEVELOPMENTS
9.12.5 BUSINESS STRATEGY
9.12.6 SWOT ANALYSIS
LIST OF TABLES
TABLE 1 PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 40
TABLE 2 NEUROMONITORING DEVICES AVERAGE SELLING PRICE, NUMBER OF UNITS SOLD AND INSTALLED BASE BY REGION, (2020) (NO.S) 144
TABLE 3 CARDIAC MONITORING DEVICES AVERAGE SELLING PRICE, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION, (2020) (NO.S) 146
TABLE 4 FETAL AND NEONATAL MONITORING DEVICES AVERAGE SELLING PRICE, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION, (2020) (NO.S) 147
TABLE 5 RESPIRATORY MONITORING DEVICES AVERAGE SELLING PRICE, NUMBER OF UNITS SOLD AND INSTALLED BASE BY REGION, (2020) (NO.S) 148
TABLE 6 TEMPERATURE MONITORING DEVICES AVERAGE SELLING PRICE AND NUMBER OF UNITS SOLD, BY REGION, (2020) (NO.S) 150
TABLE 7 HEMODYNAMIC MONITORING DEVICES AVERAGE SELLING PRICE, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION, (2020) (NO.S) 151
TABLE 8 MULTI-PARAMETER MONITORING DEVICES AVERAGE SELLING PRICE, NUMBER OF UNITS SOLD AND INSTALLED BASE, BY REGION, (2020) (NO.S) 152
TABLE 9 BLOOD GLUCOSE MONITORING DEVICES AVERAGE SELLING PRICE AND NUMBER OF UNITS SOLD, BY REGION, (2020) (NO.S) 153
TABLE 10 PATIENT MONITORING GLOBAL MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 155
TABLE 11 NEUROMONITORING GLOBAL MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 158
TABLE 12 NEUROMONITORING GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 160
TABLE 13 EEG GLOBAL MARKET REVENUE, BY DEVICES, (2019-2027) ($MN) 163
TABLE 14 8-CHANNEL EEG GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 165
TABLE 15 21-CHANNEL EEG GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 167
TABLE 16 25-CHANNEL EEG GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 168
TABLE 17 32-CHANNEL EEG GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 170
TABLE 18 40-CHANNEL EEG GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 171
TABLE 19 MULTI-CHANNEL EEG GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 172
TABLE 20 CEREBRAL OXIMETER GLOBAL MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 174
TABLE 21 CEREBRAL OXIMETER GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 176
TABLE 22 CEREBRAL OXIMETER MONITOR GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 177
TABLE 23 CEREBRAL OXIMETER SENSORS GLOBAL MARKET REVENUE,
BY DETECTORS, (2019-2027) ($MN) 179
TABLE 24 CEREBRAL OXIMETER SENSORS GLOBAL MARKET REVENUE,
BY REGION, (2019-2027) ($MN) 181
TABLE 25 SINGLE EMITTER DUAL DETECTOR GLOBAL MARKET REVENUE,
BY REGION, (2019-2027) ($MN) 182
TABLE 26 DUAL EMITTER DUAL DETECTOR GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 184
TABLE 27 FOUR EMITTER DUAL DETECTOR GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 185
TABLE 28 FIVE EMITTER DUAL DETECTOR GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 186
TABLE 29 OTHER SENSORS GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 187
TABLE 30 ICP MONITOR GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 189
TABLE 31 MEG GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 192
TABLE 32 EMG GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 193
TABLE 33 HEMODYNAMIC MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 195
TABLE 34 HEMODYNAMIC MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 197
TABLE 35 BLOOD PRESSURE MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 199
TABLE 36 CARDIAC OUTPUT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 201
TABLE 37 BLOOD GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 203
TABLE 38 BLOOD GLUCOSE MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 205
TABLE 39 SBGM GLOBAL MARKET REVENUE, BY DEVICES, (2019-2027) ($MN) 207
TABLE 40 SBGM GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 209
TABLE 41 BLOOD GLUCOSE METERS GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 211
TABLE 42 BLOOD GLUCOSE TESTING STRIPS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 213
TABLE 43 LANCETS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 214
TABLE 44 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 216
TABLE 45 CGM GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 218
TABLE 46 CGM GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 220
TABLE 47 GLUCOSE SENSORS GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 222
TABLE 48 TRANSMITTER AND RECEIVER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 223
TABLE 49 CARDIAC MONITORING GLOBAL MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 225
TABLE 50 CARDIAC MONITOR GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 227
TABLE 51 12-LEAD ECG GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 229
TABLE 52 EVENT MONITORS GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 230
TABLE 53 HOLTER MONITORS GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 231
TABLE 54 FETAL AND NEONATAL MONITORING GLOBAL MARKET REVENUE,
BY DEVICE, (2019-2027) ($MN) 233
TABLE 55 FETAL AND NEONATAL GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 235
TABLE 56 FETAL MONITORS GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 237
TABLE 57 FETAL DOPPLER GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 239
TABLE 58 INFANT INCUBATOR GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 241
TABLE 59 NEONATAL MONITORING GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 242
TABLE 60 RESPIRATORY MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 244
TABLE 61 RESPIRATORY MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 246
TABLE 62 CAPNOGRAPHY GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 248
TABLE 63 SPIROMETER GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 251
TABLE 64 SPIROMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 253
TABLE 65 VOLUMETRIC SPIROMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 255
TABLE 66 FLOW MEASURING SPIROMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 256
TABLE 67 PSG GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 258
TABLE 68 PULSE OXIMETER GLOBAL MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 260
TABLE 69 PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 262
TABLE 70 FINGERTIP PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 263
TABLE 71 HANDHELD PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 265
TABLE 72 TABLETOP PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 266
TABLE 73 OTHER PULSE OXIMETER GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 269
TABLE 74 OTHER RESPIRATORY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 272
TABLE 75 MULTI-PARAMETER MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 274
TABLE 76 MULTI-PARAMETER GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 276
TABLE 77 HIGH ACUITY GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 278
TABLE 78 MID ACUITY GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 280
TABLE 79 LOW ACUITY GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 281
TABLE 80 TEMPERATURE MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 283
TABLE 81 TEMPERATURE MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 285
TABLE 82 DIGITAL THERMOMETER GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 287
TABLE 83 IR THERMOMETER GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 289
TABLE 84 OTHER THERMOMETER GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 290
TABLE 85 REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 293
TABLE 86 REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 295
TABLE 87 REMOTE NEUROMONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 296
TABLE 88 REMOTE HEMODYNAMIC MONITORING GLOBAL MARKET REVENUE,
BY REGION, (2019-2027) ($MN) 298
TABLE 89 REMOTE CARDIAC MONITORING GLOBAL MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 300
TABLE 90 REMOTE CARDIAC MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 302
TABLE 91 IMPLANTABLE LOOP RECORDER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 303
TABLE 92 MOBILE CARDIAC TELEMETRY GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 305
TABLE 93 REMOTE MULTI-PARAMETER MONITORING GLOBAL MARKET REVENUE,
BY REGION, (2019-2027) ($MN) 307
TABLE 94 OTHER REMOTE PATIENT MONITORING GLOBAL MARKET REVENUE,
BY REGION, (2019-2027) ($MN) 309
TABLE 95 PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE,
BY PORTABILITY, (2019-2027) ($MN) 312
TABLE 96 STATIONARY PATIENT MONITORING GLOBAL MARKET REVENUE,
BY REGION, (2019-2027) ($MN) 315
TABLE 97 PORTABLE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 317
TABLE 98 WEARABLE PATIENT MONITORING GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 319
TABLE 99 IMPLANTABLE PATIENT MONITORING GLOBAL MARKET REVENUE,
BY REGION, (2019-2027) ($MN) 320
TABLE 100 PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE,
BY END-USER, (2019-2027) ($MN) 322
TABLE 101 HOSPITAL GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 325
TABLE 102 AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE,
BY REGION, (2019-2027) ($MN) 330
TABLE 103 HOME HEALTHCARE GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 332
TABLE 104 OTHER END-USER GLOBAL MARKET REVENUE, BY REGION,
(2019-2027) ($MN) 334
TABLE 105 PATIENT MONITORING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN) 336
TABLE 106 N.A. PATIENT MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 344
TABLE 107 N.A. NEUROMONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 346
TABLE 108 N.A. EEG MARKET REVENUE, BY DEVICES, (2019-2027) ($MN) 348
TABLE 109 N.A. CEREBRAL OXIMETER MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 350
TABLE 110 N.A. CEREBRAL OXIMETER SENSORS MARKET REVENUE, BY DETECTOR, (2019-2027) ($MN) 352
TABLE 111 N.A. HEMODYNAMIC MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 354
TABLE 112 N.A. BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 356
TABLE 113 N.A. SBGM MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 358
TABLE 114 N.A. CGM MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 360
TABLE 115 N.A. CARDIAC MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 362
TABLE 116 N.A. FETAL AND NEONATAL CARE MONITORING MARKET REVENUE,
BY DEVICE, (2019-2027) ($MN) 364
TABLE 117 N.A. RESPIRATORY MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 366
TABLE 118 N.A. SPIROMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 368
TABLE 119 N.A. PULSE OXIMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 370
TABLE 120 N.A. MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 372
TABLE 121 N.A. TEMPERATURE MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 374
TABLE 122 N.A. REMOTE PATIENT MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 376
TABLE 123 N.A REMOTE CARDIAC MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 378
TABLE 124 N.A. PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY, (2019-2027) ($MN) 380
TABLE 125 N.A. PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER, (2019-2027) ($MN) 382
TABLE 126 N.A. PATIENT MONITORING DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN) 384
TABLE 127 E.U. PATIENT MONITORING MARKET REVENUE, BY DEVICES,
(2019-2027) ($MN) 413
TABLE 128 E.U. NEUROMONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 415
TABLE 129 E.U. EEG MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 417
TABLE 130 E.U. CEREBRAL OXIMETER MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 419
TABLE 131 E.U. CEREBRAL OXIMETER SENSORS MARKET REVENUE, BY DETECTOR, (2019-2027) ($MN) 421
TABLE 132 E.U. HEMODYNAMIC MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 423
TABLE 133 E.U. BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 425
TABLE 134 E.U. SBGM MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 427
TABLE 135 E.U. CGM MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 429
TABLE 136 E.U. CARDIAC MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 431
TABLE 137 E.U. FETAL AND NEONATAL MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 433
TABLE 138 E.U. RESPIRATORY MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 435
TABLE 139 E.U. SPIROMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 437
TABLE 140 E.U. PULSE OXIMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 439
TABLE 141 E.U. MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 441
TABLE 142 E.U. TEMPERATURE MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 443
TABLE 143 E.U. REMOTE PATIENT MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 445
TABLE 144 E.U. REMOTE CARDIAC MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 447
TABLE 145 E.U. PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY, (2019-2027) ($MN) 449
TABLE 146 E.U. PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER, (2019-2027) ($MN) 451
TABLE 147 E.U. PATIENT MONITORING DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN) 453
TABLE 148 APAC PATIENT MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 500
TABLE 149 APAC NEUROMONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 502
TABLE 150 APAC EEG MARKET REVENUE, BY DEVICES, (2019-2027) ($MN) 504
TABLE 151 APAC CEREBRAL OXIMETER MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 506
TABLE 152 APAC CEREBRAL OXIMETER SENSORS MARKET REVENUE, BY DETECTOR, (2019-2027) ($MN) 508
TABLE 153 APAC HEMODYNAMIC MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 510
TABLE 154 APAC BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 512
TABLE 155 APAC SBGM MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 514
TABLE 156 APAC CGM MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 516
TABLE 157 APAC CARDIAC MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 518
TABLE 158 APAC FETAL AND NEONATAL CARE MONITORING MARKET REVENUE,
BY DEVICE, (2019-2027) ($MN) 520
TABLE 159 APAC RESPIRATORY MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 522
TABLE 160 APAC SPIROMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 524
TABLE 161 APAC PULSE OXIMETER MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 526
TABLE 162 APAC MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 528
TABLE 163 APAC TEMPERATURE MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 530
TABLE 164 APAC REMOTE PATIENT MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 532
TABLE 165 APAC REMOTE CARDIAC MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 534
TABLE 166 APAC PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY, (2019-2027) ($MN) 536
TABLE 167 APAC PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER, (2019-2027) ($MN) 538
TABLE 168 APAC PATIENT MONITORING DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN) 540
TABLE 169 ROW PATIENT MONITORING MARKET REVENUE, BY DEVICES,
(2019-2027) ($MN) 586
TABLE 170 ROW NEUROMONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 588
TABLE 171 ROW EEG MARKET REVENUE, BY DEVICES, (2019-2027) ($MN) 590
TABLE 172 ROW CEREBRAL OXIMETER MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 592
TABLE 173 ROW CEREBRAL OXIMETER SENSORS MARKET REVENUE, BY DETECTOR, (2019-2027) ($MN) 594
TABLE 174 ROW HEMODYNAMIC MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 596
TABLE 175 ROW BLOOD GLUCOSE MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 598
TABLE 176 ROW SBGM MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 600
TABLE 177 ROW CGM MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 602
TABLE 178 ROW CARDIAC MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 604
TABLE 179 ROW FETAL AND NEONATAL MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 606
TABLE 180 ROW RESPIRATORY MONITORING MARKET REVENUE, BY DEVICE,
(2019-2027) ($MN) 608
TABLE 181 ROW SPIROMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 610
TABLE 182 ROW PULSE OXIMETER MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 612
TABLE 183 ROW MULTI-PARAMETER MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 614
TABLE 184 ROW TEMPERATURE MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 616
TABLE 185 ROW REMOTE PATIENT MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 618
TABLE 186 ROW REMOTE CARDIAC MONITORING MARKET REVENUE, BY DEVICE, (2019-2027) ($MN) 620
TABLE 187 ROW PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY, (2019-2027) ($MN) 622
TABLE 188 ROW PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER, (2019-2027) ($MN) 624
TABLE 189 ROW PATIENT MONITORING DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN) 626
TABLE 190 APPROVALS (2018-2020) 659
TABLE 191 AGREEMENTS, PARTNERSHIP AND COLLABORATION (2018-2020) 668
TABLE 192 NEW PRODUCT LAUNCH (2018-2020) 672
TABLE 193 ACQUISITION (2018-2020) 674
TABLE 194 ACQUISITION (2018-2020) 675
TABLE 195 ABBOTT LABORATORIES, INC.: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN) 679
TABLE 196 ABBOTT LABORATORIES, INC.: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN) 680
TABLE 197 ABBOTT LABORATORIES, INC.: MEDICAL DEVICES REVENUE, BY SUB-SEGMENTS, (2017-2019) ($MN) 681
TABLE 198 ABBOTT LABORATORIES, INC.: TOTAL REVENUE, BY GEOGRAPHY,
(2017-2019) ($MN) 682
TABLE 199 DEXCOM, INC.: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN) 688
TABLE 200 DEXCOM, INC.: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN) 689
TABLE 201 DEXCOM, INC.: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) ($MN) 690
TABLE 202 DRAGERWERK AG & CO. KGAA: TOTAL REVENUE AND R&D EXPENSES (2017–2019) ($MN) 695
TABLE 203 DRAGERWERK AG & CO. KGAA: TOTAL REVENUE, BY SEGMENTS
(2017-2019) ($MN) 696
TABLE 204 DRAGERWERK AG & CO. KGAA: TOTAL REVENUE, BY REGION
(2017-2019) ($MN) 697
TABLE 205 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN) 701
TABLE 206 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN) 702
TABLE 207 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2017-2019)($MN) 703
TABLE 208 GE COMPANY: TOTAL REVENUE AND R&D EXPENSES (2017 – 2019) ($MN) 708
TABLE 209 GE COMPANY: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN) 709
TABLE 210 GE COMPANY: TOTAL REVENUE, BY HEALTHCARE SEGMENT
(2017 –2019) ($MN) 710
TABLE 211 GE COMPANY: TOTAL REVENUE, BY GEOGRAPHY (2017 –2019) ($MN) 711
TABLE 212 HILL-ROM HOLDINGS, INC.: TOTAL REVENUE AND R&D EXPENSES
(2018 – 2020) (Q2) ($MN) 717
TABLE 213 HILL-ROM HOLDINGS, INC.: TOTAL REVENUE, BY SEGMENTS (2018-2020) (Q2) ($MN) 718
TABLE 214 HILL-ROM HOLDINGS, INC.: TOTAL REVENUE, BY GEOGRAPHY
(2018 –2020) (Q2) ($MN) 719
TABLE 215 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES,
(2017-2019) ($MN) 724
TABLE 216 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS,
(2017-2019) ($MN) 725

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook